These findings show a novel autoenhancing EZH2_circEZH2-miR363/miR708_EZH2 regulatory loop, by which circEZH2 plays important roles in PCa tumorigenesis and progression by upregulating EZH2, and may have potential diagnostic, prognostic, and therapeutic uses in PCa management.
circEZH2(E2) (/E3) is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression.